110 related articles for article (PubMed ID: 8921926)
1. Circulating transferrin receptor during erythropoietin medication of anemic patients with rheumatoid arthritis.
Pettersson T; Teppo AM; Siimes MA
Scand J Rheumatol; 1996; 25(5):321-4. PubMed ID: 8921926
[TBL] [Abstract][Full Text] [Related]
2. Erythroblast iron metabolism and serum soluble transferrin receptor values in the anemia of rheumatoid arthritis.
Fitzsimons EJ; Houston T; Munro R; Sturrock RD; Speekenbrink AB; Brock JH
Arthritis Rheum; 2002 Apr; 47(2):166-71. PubMed ID: 11954010
[TBL] [Abstract][Full Text] [Related]
3. Iron stores and serum transferrin receptor levels during recombinant human erythropoietin treatment of anemia in rheumatoid arthritis.
Vreugdenhil G; Manger B; Nieuwenhuizen C; Feelders RA; van Eijk HG; Swaak AJ
Ann Hematol; 1992 Dec; 65(6):265-8. PubMed ID: 1457588
[TBL] [Abstract][Full Text] [Related]
4. Markers of masked iron deficiency and effectiveness of EPO therapy in chronic renal failure.
Ahluwalia N; Skikne BS; Savin V; Chonko A
Am J Kidney Dis; 1997 Oct; 30(4):532-41. PubMed ID: 9328369
[TBL] [Abstract][Full Text] [Related]
5. The effects of recombinant human erythropoietin on autologous blood donation in rheumatoid arthritis patients with anaemia.
Matsui H; Shiraishi N; Yasuda T; Nezuka T
Clin Exp Rheumatol; 1999; 17(1):69-74. PubMed ID: 10084035
[TBL] [Abstract][Full Text] [Related]
6. Early prediction of response to recombinant human erythropoietin in patients with the anemia of renal failure by serum transferrin receptor and fibrinogen.
Beguin Y; Loo M; R'Zik S; Sautois B; Lejeune F; Rorive G; Fillet G
Blood; 1993 Oct; 82(7):2010-6. PubMed ID: 8400253
[TBL] [Abstract][Full Text] [Related]
7. Association between transferrin receptor-ferritin index and conventional measures of iron responsiveness in hemodialysis patients.
Chen YC; Hung SC; Tarng DC
Am J Kidney Dis; 2006 Jun; 47(6):1036-44. PubMed ID: 16731299
[TBL] [Abstract][Full Text] [Related]
8. Successful treatment of the anemia of rheumatoid arthritis with subcutaneously administered recombinant human erythropoietin. Slower response in patients with more severe inflammation.
Pettersson T; Rosenlöf K; Friman C; Mickos A; Teppo AM; Fyhrquist F
Scand J Rheumatol; 1993; 22(4):188-93. PubMed ID: 8356412
[TBL] [Abstract][Full Text] [Related]
9. Suppressed serum erythropoietin response to anemia and the efficacy of recombinant erythropoietin in the anemia of rheumatoid arthritis.
Takashina N; Kondo H; Kashiwazaki S
J Rheumatol; 1990 Jul; 17(7):885-7. PubMed ID: 2213753
[TBL] [Abstract][Full Text] [Related]
10. Effect of exogenous erythropoietin on haem synthesis in anaemic patients with rheumatoid arthritis.
Pettersson T; Rosenlöf K; Laitinen E; Tenhunen R
Br J Rheumatol; 1994 Jun; 33(6):526-9. PubMed ID: 8205399
[TBL] [Abstract][Full Text] [Related]
11. Serum transferrin receptor levels in anaemic patients with rheumatoid arthritis.
Nielsen OJ; Andersen LS; Hansen NE; Hansen TM
Scand J Clin Lab Invest; 1994 Feb; 54(1):75-82. PubMed ID: 8171275
[TBL] [Abstract][Full Text] [Related]
12. Autologous blood transfusion with recombinant erythropoietin treatment. 22 arthroplasties for rheumatoid arthritis.
Saikawa I; Hotokebuchi T; Arita C; Inaba S; Shuto T; Tsutsui H; Sugioka Y
Acta Orthop Scand; 1994 Feb; 65(1):15-9. PubMed ID: 8154276
[TBL] [Abstract][Full Text] [Related]
13. Correction of iron-deficient erythropoiesis in the treatment of anemia of chronic disease with recombinant human erythropoietin.
Arndt U; Kaltwasser JP; Gottschalk R; Hoelzer D; Möller B
Ann Hematol; 2005 Mar; 84(3):159-66. PubMed ID: 15565327
[TBL] [Abstract][Full Text] [Related]
14. [Effects of the chemokine MIP-1alpha on anemia and inflammation in rheumatoid arthritis].
Kullich W; Niksic F; Burmucic K; Pöllmann G; Klein G
Z Rheumatol; 2002 Oct; 61(5):568-76. PubMed ID: 12399885
[TBL] [Abstract][Full Text] [Related]
15. Anemia associated with advanced prostatic adenocarcinoma: effects of recombinant human erythropoietin.
Beshara S; Letocha H; Linde T; Wikström B; Sandhagen B; Nilsson S; Danielson BG
Prostate; 1997 May; 31(3):153-60. PubMed ID: 9167766
[TBL] [Abstract][Full Text] [Related]
16. Serum transferrin receptor levels in patients with rheumatoid arthritis are correlated with indicators for anaemia.
Chijiwa T; Nishiya K; Hashimoto K
Clin Rheumatol; 2001; 20(5):307-13. PubMed ID: 11642510
[TBL] [Abstract][Full Text] [Related]
17. Quantitative assessment of erythropoiesis in haemodialysis patients demonstrates gradual expansion of erythroblasts during constant treatment with recombinant human erythropoietin.
Beguin Y; Loo M; R'Zik S; Sautois B; Lejeune F; Rorive G; Fillet G
Br J Haematol; 1995 Jan; 89(1):17-23. PubMed ID: 7833259
[TBL] [Abstract][Full Text] [Related]
18. Subcutaneous recombinant human erythropoietin for the treatment of anemia in myelodysplastic syndromes.
Ghio R; Balleari E; Ballestrero A; Gatti AM; Mareni C; Massa G; Patrone F; Sessarego M; Timitilli S
Acta Haematol; 1993; 90(2):58-64. PubMed ID: 8285019
[TBL] [Abstract][Full Text] [Related]
19. Cross sectional, comparative study of serum erythropoietin, transferrin receptor, ferritin levels and other hematological indices in normal pregnancies and iron deficiency anemia during pregnancy.
Sharma JB; Bumma SD; Saxena R; Kumar S; Roy KK; Singh N; Vanamail P
Eur J Obstet Gynecol Reprod Biol; 2016 Aug; 203():99-103. PubMed ID: 27267870
[TBL] [Abstract][Full Text] [Related]
20. Autologous blood transfusion with recombinant erythropoietin treatment in anaemic patients with rheumatoid arthritis.
Tanaka N; Ito K; Ishii S; Yamazaki I
Clin Rheumatol; 1999; 18(4):293-8. PubMed ID: 10468168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
